Roundtable 8: Exploring the safety considerations of CRISPR technology and different approaches to epigenetic editing

Name: Roundtable 8: Exploring the safety considerations of CRISPR technology and different approaches to epigenetic editing
Start: 2027-03-09T13:10
Location: ExCeL London

Advanced Therapies UK 2027 · 9 March 2027 · 13:10 · Keynote Theatre

Roundtable 8: Exploring the safety considerations of CRISPR technology and different approaches to epigenetic editing was a session at Advanced Therapies UK 2027 on 9 March 2027 in London, with 2 speakers on record.

Speakers

Sibtain Haider — Moderator Postdoctoral Researcher, University Hospital Freiburg
Anna-Lina Cavallo — Moderator Director Discovery Cell and Gene Therapy integrated Bioanalysis, AstraZeneca